Table 4.
Complete blood counts before and after treatment
| Parameter | Before treatment (n = 27) | After treatment (n = 27) | P-value | ||
|---|---|---|---|---|---|
| Range | Mean ± SD | Range | Mean ± SD | ||
| Hb (g/dl) | 6.1–11.4 | 9.7 ± 1.2 | 8.6–13.7 | 11.4 ± 1.2 | 0.000* |
| PCV % | 19.0–36.6 | 30.0 ± 3.8 | 28.2–44.2 | 36.2 ± 3.6 | 0.000* |
| RBC (×1012/l) | 3.14–4.84 | 3.66 ± 0.44 | 3.34–5.51 | 4.06 ± 0.59 | 0.000* |
| MCV (fl) | 55.6–81.5 | 71.9 ± 7.3 | 70.2–89.5 | 80.1 ± 5.1 | 0.000* |
| MCH (pg) | 18.6–28.3 | 24.5 ± 2.8 | 19.9–30.8 | 27.2 ± 2.6 | 0.000* |
| MCHC (g/l) | 26.0–33.2 | 30.0 ± 1.9 | 25.4–35.3 | 31.8 ± 2.3 | 0.001* |
| P/C (×109/l) | 165–473 | 257.2 ± 84.3 | 165–445 | 271.2 ± 81.4 | 0.313 |
| TLC (×109/l) | 3.41–9.70 | 6.55 ± 1.63 | 3.47–12.40 | 6.86 ± 1.82 | 0.275 |
(Paired Student t test) * Significant